Concurrent chemoradiotherapy with or without neoadjuvant chemotherapy in pediatric patients with stage III-IVa nasopharyngeal carcinoma: a real-world propensity score-matched cohort study

被引:0
|
作者
Ya-Nan Jin
Zhao-Hui Ruan
Wan-Wei Cao
Lin Yang
Wei Yao
Xiao-Feng Pei
Wang-Jian Zhang
Tia Marks
Ji-Jin Yao
Liang-Ping Xia
机构
[1] Sun Yat-Sen University Cancer Center,VIP Region, State Key Laboratory of Oncology in South China, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Collaborative Innovation Center for Cancer Medicine
[2] The Cancer Center of the Fifth Affiliated Hospital of Sun Yat-Sen University,Department of Pathology
[3] The Fifth Affiliated Hospital of Sun Yat-Sen University,Department of Radiation Oncology
[4] Nanfang Hospital,Department of Medical Statistics, School of Public Health
[5] Southern Medical University,Department of Environmental Health Sciences, School of Public Health
[6] Sun Yat-Sen University,undefined
[7] University at Albany,undefined
[8] State University of New York,undefined
[9] Guangdong Provincial Key Laboratory of Biomedical Imaging,undefined
来源
Journal of Cancer Research and Clinical Oncology | 2023年 / 149卷
关键词
Nasopharyngeal carcinoma; Propensity score matching; Neoadjuvant chemotherapy; Concurrent chemoradiotherapy; Children and adolescents;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:11929 / 11940
页数:11
相关论文
共 50 条
  • [21] With or without consolidation chemotherapy using cisplatin/5-FU after concurrent chemoradiotherapy in stage II-III squamous cell carcinoma of the esophagus: A propensity score-matched analysis
    Chen, Yongshun
    Guo, Liying
    Cheng, Xinyu
    Wang, Jun
    Zhang, Yougai
    Wang, Yi
    Ke, Shaobo
    Shi, Wei
    RADIOTHERAPY AND ONCOLOGY, 2018, 129 (01) : 154 - 160
  • [22] Neoadjuvant versus adjuvant chemoradiotherapy for stage II-III esophageal squamous cell carcinoma: A propensity score-matched analysis.
    Lv, Jiahua
    Li, Tao
    Wang, Qifeng
    Han, Yongtao
    Song, Yuzhe
    Liang, Long
    Chen, Meihua
    Fan, Yu
    Wu, Lei
    Peng, Lin
    Lang, Jinyi
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [23] Effectiveness of Cetuximab in Combination with Concurrent Chemoradiotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma: A 1:2 Propensity Score-matched Analysis
    Wu, Li-Rong
    Zhu, Huan-feng
    Xu, Jianhua
    Jiang, Xue-song
    Yin, Li
    Jiang, Ning
    Zong, Dan
    Wang, Fei-jiang
    Huang, Sheng-fu
    Bian, Xiu-hua
    Wu, Jian-feng
    Song, Dan
    Guo, Wen-jie
    Liu, Ju-Ying
    He, Xia
    JOURNAL OF CANCER, 2018, 9 (09): : 1642 - 1650
  • [24] Concurrent chemoradiotherapy with weekly docetaxel versus cisplatin in the treatment of locoregionally advanced nasopharyngeal carcinoma: a propensity score-matched analysis
    Liao, Jun-Fang
    Zhang, Qun
    Du, Xiao-Jing
    Lan, Mei
    Liu, Shan
    Xia, Yun-Fei
    Cai, Xiu-Yu
    Luo, Wei
    CANCER COMMUNICATIONS, 2019, 39
  • [25] Neoadjuvant chemotherapy or chemoradiation for patients with advanced adenocarcinoma of the oesophagus? A propensity score-matched study
    Favi, F.
    Bollschweiler, E.
    Berlth, F.
    Plum, P.
    Hecheler, D.
    Alakus, H.
    Semrau, R.
    Celik, E.
    Moenig, S. P.
    Drebber, U.
    Hoelscher, A. H.
    EJSO, 2017, 43 (08): : 1572 - 1580
  • [26] Concurrent Chemoradiotherapy With or Without Induction Chemotherapy for Patients with Stage II Nasopharyngeal Carcinoma: An Update
    Jin, Ting
    Zhang, Qun
    Luo, Dong-Hua
    Jiang, Feng
    Jin, Qi-Feng
    Chen, Yuan-Yuan
    Chen, Xiao-Zhong
    Mao, Wei-Min
    TRANSLATIONAL ONCOLOGY, 2020, 13 (01): : 25 - 31
  • [27] Comparison of neoadjuvant chemoradiotherapy versus chemoradiotherapy plus immunotherapy for esophageal squamous cell carcinoma in a real-world multicenter cohort: a propensity score matching study
    Shi, Shuming
    Zhou, Hao
    Li, Li
    Xu, Fuhao
    Liu, Ning
    Zhang, Dexian
    Xu, Xiaohui
    Sun, Yawen
    Yuan, Shuanghu
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [28] Efficacy and Safety of Concurrent Chemoradiotherapy Combined With Induction Chemotherapy or Adjuvant Chemotherapy in Patients With Stage II-IVA Nasopharyngeal Carcinoma: A Propensity Score Matching Analysis and Meta-Analysis
    Yang, Jie
    Liang, Zhong-Guo
    Jiang, Yu-Ting
    Chen, Kai-Hua
    Li, Ling
    Qu, Song
    Zhu, Xiao-Dong
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [29] Induction chemotherapy with sequential nimotuzumab plus concurrent chemoradiotherapy in advanced nasopharyngeal carcinoma: A retrospective real-world study
    Jiang, Danxian
    Cao, Jinxin
    Guo, Linying
    Chen, Yonghua
    Yuan, Ge
    Huang, Jing
    MEDICINE, 2023, 102 (04) : E32732
  • [30] Neoadjuvant chemoradiotherapy versus neoadjuvant chemotherapy for the treatment of esophageal squamous cell carcinoma: a propensity score-matched study from the National Cancer Center in China
    Zhang, Guochao
    Zhang, Chaoqi
    Sun, Nan
    Xue, Liyan
    Yang, Zhaoyang
    Fang, Lingling
    Zhang, Zhihui
    Luo, Yuejun
    Gao, Shugeng
    Xue, Qi
    Mu, Juwei
    Gao, Yushun
    Tan, Fengwei
    He, Jie
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2022, 148 (04) : 943 - 954